tiprankstipranks
Advertisement
Advertisement

IBRX Stock Latest News

ImmunityBio presents new comparison results on Anktiva, TAR-200
The FlyImmunityBio presents new comparison results on Anktiva, TAR-200
2d ago
IBRX
ImmunityBio Targets Tough Pancreatic Cancer With New Phase 1 Combo Trial
PremiumCompany Announcements
ImmunityBio Targets Tough Pancreatic Cancer With New Phase 1 Combo Trial
7d ago
IBRX
ImmunityBio announces availability of ANKTIVA in Saudi Arabia
PremiumThe Fly
ImmunityBio announces availability of ANKTIVA in Saudi Arabia
16d ago
IBRX
ImmunityBio call volume above normal and directionally bullish
PremiumThe Fly
ImmunityBio call volume above normal and directionally bullish
16d ago
IBRX
ImmunityBio Faces Lawsuit Over Anktiva Promotion After FDA Warning Letter
PremiumClass Action
ImmunityBio Faces Lawsuit Over Anktiva Promotion After FDA Warning Letter
20d ago
IBRX
ImmunityBio reports preliminary Q1 net product revenue $44.2M
PremiumThe FlyImmunityBio reports preliminary Q1 net product revenue $44.2M
28d ago
IBRX
ImmunityBio Addresses FDA Warning on ANKTIVA Promotion
Premium
Company Announcements
ImmunityBio Addresses FDA Warning on ANKTIVA Promotion
1M ago
8K
IBRX
ImmunityBio addresses FDA correspondence, reaffirms commitment to ad compliance
Premium
The Fly
ImmunityBio addresses FDA correspondence, reaffirms commitment to ad compliance
1M ago
IBRX
ImmunityBio, Keysight, Rubrik, AFLAC, Moody’s Insider Shake-Up
PremiumWeekend Updates
ImmunityBio, Keysight, Rubrik, AFLAC, Moody’s Insider Shake-Up
1M ago
AFL
MCO
ImmunityBio Bolsters Balance Sheet With New Financing Moves
PremiumCompany Announcements
ImmunityBio Bolsters Balance Sheet With New Financing Moves
1M ago
8K
IBRX
ImmunityBio announces $100M of financing transactions
PremiumThe Fly
ImmunityBio announces $100M of financing transactions
1M ago
IBRX
IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Soon-Shiong Allegedly Overstated ANKTIVA Efficacy: Levi & Korsinsky
PremiumClass Action
IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Soon-Shiong Allegedly Overstated ANKTIVA Efficacy: Levi & Korsinsky
1M ago
IBRX
ImmunityBio Faces Securities Lawsuit Over Alleged Misleading Statements About Cancer Drug Anktiva
PremiumClass ActionImmunityBio Faces Securities Lawsuit Over Alleged Misleading Statements About Cancer Drug Anktiva
1M ago
IBRX
ImmunityBio announces IDMC says QUILT-2.005 adequately powered
Premium
The Fly
ImmunityBio announces IDMC says QUILT-2.005 adequately powered
1M ago
IBRX
Mixed options sentiment in ImmunityBio with shares up 6.88%
Premium
The Fly
Mixed options sentiment in ImmunityBio with shares up 6.88%
1M ago
IBRX
“FDA Warning” on Cancer Drug Sends ImmunityBio Stock (IBRX) Tumbling over 26%
PremiumMarket News
“FDA Warning” on Cancer Drug Sends ImmunityBio Stock (IBRX) Tumbling over 26%
1M ago
IBRX
ImmunityBio’s FDA warning letter doesn’t change fundamentals, says BTIG
PremiumThe Fly
ImmunityBio’s FDA warning letter doesn’t change fundamentals, says BTIG
1M ago
IBRX
ImmunityBio falls -26.4%
PremiumThe Fly
ImmunityBio falls -26.4%
1M ago
IBRX
Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
PremiumThe Fly
Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
1M ago
EL
RL
Option traders moderately bearish in ImmunityBio with shares down 22.61%
PremiumThe FlyOption traders moderately bearish in ImmunityBio with shares down 22.61%
1M ago
IBRX
ImmunityBio falls -23.0%
Premium
The Fly
ImmunityBio falls -23.0%
1M ago
IBRX
ImmunityBio receives FDA warning letter on Anktiva promotion
Premium
The Fly
ImmunityBio receives FDA warning letter on Anktiva promotion
1M ago
IBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >